Skip to main content
. 2021 Mar 4;8(4):ofab098. doi: 10.1093/ofid/ofab098

Table 1.

Demographics and Clinical Presentation of Pyomyositis and Infectious Myositis

Demographics and Clinical Information Staphylococcal Species (N = 28) Streptococcal Species (N = 7) Culture-Negative (N = 16) Other (N = 10) Total (N = 61) P Value
Age (mean ± SD) 48 ± 16 47 ± 15 47 ± 21 52 ± 22 48 ± 18 .94a
Male sex (No., %) 24 (86%) 3 (43%) 8 (50%) 5 (50%) 40 (66%) .02b
Body mass indexc (kg/m2) (mean ± SD) 29 ± 4 27 ± 2 27 ± 3 27 ± 5 28 ± 4 .49a
Diabetes mellitus (No., %) 11 (39%) 2 (29%) 4 (25%) 3 (30%) 20 (33%) .81b
Immunocompromising comorbidityd (No., %) 3 (11%) 1 (14%) 1 (6%) 5 (50%) 10 (16%) .03b
Clinical Presentation
Pyomyositis cases (No., %) 24 (86%) 5 (71%) 8 (50%) 6 (60%) 43 (70%) .06b
Myositis cases (No., %) 4 (14%) 2 (29%) 8 (50%) 4 (40%) 18 (30%) .06b
Intravenous drug use in past month (No., %) 3 (11%) 3 (43%) 2 (13%) 0 8 (13%) .10b
Rigorous exercise in past month (No., %) 3 (11%) 0 1 (6%) 0 4 (7%) .88b
No. of days between symptom onset and presentation (median, range) 7 (1–30) 4 (2–21) 3 (1–21) 8 (1–30) 5 (1–30) .19a
Muscle pain (No., %) 27 (96%) 6 (86%) 16 (100%) 9 (90%) 58 (95%) .26b
Tenderness to palpation (No., %) 18 (64%) 5 (71%) 13 (81%) 6 (60%) 42 (69%) .60b
Strength or range of motion change (No., %) 7 (25%) 2 (29%) 7 (44%) 4 (40%) 20 (33%) .61b
Area of induration or palpable mass (No., %) 9 (32%) 2 (29%) 3 (19%) 3 (30%) 17 (28%) .86b
Subjective fever (No., %) 13 (46%) 5 (71%) 7 (44%) 5 (50%) 30 (49%) .70b
Malaise (No., %) 11 (39%) 3 (43%) 5 (31%) 6 (60%) 25 (41%) .57b
Night sweats (No., %) 3 (11%) 1 (14%) 2 (13%) 1 (10%) 7 (11%) 1.00b
Weight loss (No., %) 3 (11%) 0 0 1 (10%) 4 (7%) .55b
Altered mental status (No., %) 6 (21%) 0 2 (13%) 2 (20%) 10 (16%) .66b
Temperature (mean ± SD, °F) 100.0 ± 1.6 101.0 ± 2.2 100.0 ± 1.8 100.2 ± 2.3 100.1 ± 1.8 .62a
White blood cell count (103/μL) (mean ± SD) 15 ± 6 14 ± 4 12 ± 3 13 ± 6 14 ± 5 .17a
≥5% bands (No., %) 6 (21%) 3 (43%) 1 (6%) 1 (10%) 11 (18%) .18b
Blood culture positive (No., %) 13 (46%) 1 (14%) 0 3 (30%) 17 (28%) .003b

Abbreviations: SD, standard deviation.

aOne-way analysis of variance.

bFisher’s exact test.

cOne patient’s body mass index is missing from the streptococcal species group’s data.

dCirrhosis, person with human immunodeficiency virus, hematopoietic stem cell transplant, solid organ transplant, end stage renal disease, active malignancy, or receipt of immunosuppressive regimen.